Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EADO 2018 /
EADO 2018: Melanoma roundup with a view to patients

6th - 9th Nov 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 22.11.18
Views: 693
Rating:

Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany

Dr Teresa Amaral provides a roundup of what was being discussed in melanoma at the EADO 2018 congress in Barcelona with a focus on patients.

Dr Amaral begins by acknowledging the increasing price of cancer drugs and new treatments and that, while there are now many treatments available, they are only readily available in a small proportion of countries.

She also explains the ESMO - Magnitude of Clinical Benefit Scale that asses the clinical benefit of drugs.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation